作者: Hong Ze Lin , Tao Zhang , Ming Yu Chen , Ji Liang Shen
关键词:
摘要: Gallbladder cancer (GBC) is the most common type of biliary tract malignancy with a dismal prognosis. Poor outcome in GBC patients relevant to tumor aggressive nature, delayed diagnosis without reliable biomarkers, and deficiency powerful treatments. Instead, early diagnosis, accurate assessment disease, available treatments are crucial prolong survival patients. Therefore, novel prognostic diagnostic biomarkers essential be identified, which play an important part improving rates developing remarkably targeted for We herein review prognosis interpret potential clinical significance these management.